Pharmacokinetics of Fevipiprant (QAW039) in Patients With Hepatic Impairment Compared to Matched Healthy Subjects
Clinical trial NCT03048448 · COMPLETED
Trial details
- NCT number
- NCT03048448
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-31
- Primary completion
- 2019-04-22
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.